Research ArticleClinical Investigations
15O-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases
Mark Lubberink, Sanjeep S.V. Golla, My Jonasson, Kristofer Rubin, Bengt Glimelius, Jens Sörensen and Peter Nygren
Journal of Nuclear Medicine August 2015, 56 (8) 1144-1149; DOI: https://doi.org/10.2967/jnumed.114.151894
Mark Lubberink
1Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Sanjeep S.V. Golla
1Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
My Jonasson
1Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Kristofer Rubin
2Department of Experimental Medicine, University of Lund, Lund, Sweden; and
Bengt Glimelius
3Oncology Section, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
Jens Sörensen
1Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Peter Nygren
3Oncology Section, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 56, Issue 8
August 1, 2015
15O-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases
Mark Lubberink, Sanjeep S.V. Golla, My Jonasson, Kristofer Rubin, Bengt Glimelius, Jens Sörensen, Peter Nygren
Journal of Nuclear Medicine Aug 2015, 56 (8) 1144-1149; DOI: 10.2967/jnumed.114.151894
15O-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases
Mark Lubberink, Sanjeep S.V. Golla, My Jonasson, Kristofer Rubin, Bengt Glimelius, Jens Sörensen, Peter Nygren
Journal of Nuclear Medicine Aug 2015, 56 (8) 1144-1149; DOI: 10.2967/jnumed.114.151894